<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Transl Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Transl Psychiatry</journal-id>
<journal-title-group>
<journal-title>Translational Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">2158-3188</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29391400</article-id>
<article-id pub-id-type="pmc">5804028</article-id>
<article-id pub-id-type="publisher-id">88</article-id>
<article-id pub-id-type="doi">10.1038/s41398-017-0088-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Whole-exome sequencing and gene-based rare variant association tests suggest that <italic>PLA2G4E</italic> might be a risk gene for panic disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Morimoto</surname>
<given-names>Yoshiro</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shimada-Sugimoto</surname>
<given-names>Mihoko</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Otowa</surname>
<given-names>Takeshi</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoshida</surname>
<given-names>Shintaro</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kinoshita</surname>
<given-names>Akira</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5050-2509</contrib-id>
<name>
<surname>Mishima</surname>
<given-names>Hiroyuki</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>Naohiro</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mori</surname>
<given-names>Takatoshi</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Imamura</surname>
<given-names>Akira</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ozawa</surname>
<given-names>Hiroki</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kurotaki</surname>
<given-names>Naohiro</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ziegler</surname>
<given-names>Christiane</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Domschke</surname>
<given-names>Katharina</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deckert</surname>
<given-names>Jürgen</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Umekage</surname>
<given-names>Tadashi</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tochigi</surname>
<given-names>Mamoru</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaiya</surname>
<given-names>Hisanobu</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Okazaki</surname>
<given-names>Yuji</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tokunaga</surname>
<given-names>Katsushi</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sasaki</surname>
<given-names>Tsukasa</given-names>
</name>
<xref ref-type="aff" rid="Aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoshiura</surname>
<given-names>Koh-ichiro</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7103-5372</contrib-id>
<name>
<surname>Ono</surname>
<given-names>Shinji</given-names>
</name>
<address>
<phone>+81 95 819 7118</phone>
<email>shinji1231zzz@yahoo.co.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff13">13</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8902 2273</institution-id><institution-id institution-id-type="GRID">grid.174567.6</institution-id><institution>Department of Neuropsychiatry, Unit of Translation Medicine, </institution><institution>Nagasaki University Graduate School of Biomedical Sciences, </institution></institution-wrap>Nagasaki, Japan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8902 2273</institution-id><institution-id institution-id-type="GRID">grid.174567.6</institution-id><institution>Department of Human Genetics, </institution><institution>Nagasaki University Graduate School of Biomedical Sciences, </institution></institution-wrap>Nagasaki, Japan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2151 536X</institution-id><institution-id institution-id-type="GRID">grid.26999.3d</institution-id><institution>Department of Human Genetics, Graduate School of Medicine, </institution><institution>The University of Tokyo, </institution></institution-wrap>Tokyo, Japan </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.440938.2</institution-id><institution>Graduate School of Clinical Psychology, Professional Degree Program in Clinical Psychology, </institution><institution>Teikyo Heisei University, </institution></institution-wrap>Tokyo, Japan </aff>
<aff id="Aff5"><label>5</label>Arata-clinic, Nagasaki, Japan </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1958 8658</institution-id><institution-id institution-id-type="GRID">grid.8379.5</institution-id><institution>Department of Psychiatry, Psychosomatics, and Psychotherapy, Center of Mental Health, </institution><institution>University of Würzburg, </institution></institution-wrap>Würzburg, Germany </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.5963.9</institution-id><institution>Department of Psychiatry and Psychotherapy, Medical Center–University of Freiburg, Faculty of Medicine, </institution><institution>University of Freiburg, </institution></institution-wrap>Freiburg, Germany </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2151 536X</institution-id><institution-id institution-id-type="GRID">grid.26999.3d</institution-id><institution>Division for Environment, Health and Safety, </institution><institution>The University of Tokyo, </institution></institution-wrap>Tokyo, Japan </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9239 9995</institution-id><institution-id institution-id-type="GRID">grid.264706.1</institution-id><institution>Department of Neuropsychiatry, </institution><institution>Teikyo University School of Medicine, </institution></institution-wrap>Tokyo, Japan </aff>
<aff id="Aff10"><label>10</label>Panic Disorder Research Center, Warakukai Med. Corp, Tokyo, Japan </aff>
<aff id="Aff11"><label>11</label>Department of Psychiatry, Koseikai Michino-o Hospital, Nagasaki, Japan </aff>
<aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2151 536X</institution-id><institution-id institution-id-type="GRID">grid.26999.3d</institution-id><institution>Department of Physical and Health Education, Graduate School of Education, </institution><institution>The University of Tokyo, </institution></institution-wrap>Tokyo, Japan </aff>
<aff id="Aff13"><label>13</label>Aino-Ariake Hospital, Unzen, Nagasaki, Japan </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>2</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>8</volume>
<elocation-id>41</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>9</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Panic disorder (PD) is characterized by recurrent and unexpected panic attacks, subsequent anticipatory anxiety, and phobic avoidance. Recent epidemiological and genetic studies have revealed that genetic factors contribute to the pathogenesis of PD. We performed whole-exome sequencing on one Japanese family, including multiple patients with panic disorder, which identified seven rare protein-altering variants. We then screened these genes in a Japanese PD case–control group (384 sporadic PD patients and 571 controls), resulting in the detection of three novel single nucleotide variants as potential candidates for PD (chr15: 42631993, T&gt;C in <italic>GANC</italic>; chr15: 42342861, G&gt;T in <italic>PLA2G4E</italic>; chr20: 3641457, G&gt;C in <italic>GFRA4</italic>). Statistical analyses of these three genes showed that <italic>PLA2G4E</italic> yielded the lowest <italic>p</italic> value in gene-based rare variant association tests by Efficient and Parallelizable Association Container Toolbox algorithms; however, the <italic>p</italic> value did not reach the significance threshold in the Japanese. Likewise, in a German case–control study (96 sporadic PD patients and 96 controls), <italic>PLA2G4E</italic> showed the lowest <italic>p</italic> value but again did not reach the significance threshold. In conclusion, we failed to find any significant variants or genes responsible for the development of PD. Nonetheless, our results still leave open the possibility that rare protein-altering variants in <italic>PLA2G4E</italic> contribute to the risk of PD, considering the function of this gene.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Panic disorder (PD) is characterized by recurrent and unexpected panic attacks, subsequent anticipatory anxiety, and phobic avoidance. The lifetime prevalence of PD is 4.7%, with a female preponderance<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Several genetic and epidemiological studies, including family and twin studies, have shown that genetic factors play an important role in the pathogenesis of PD. First-degree relatives of patients with PD have a sixfold greater risk for developing this disease<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, and twin studies have shown a higher concordance rate in monozygotic twins than in dizygotic ones<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Neurodevelopmental disorders, including PD, are basically considered as multifactorial diseases. Thus far, several genome-wide association studies (GWAS) using DNA microarrays have focused on PD, but they have not been consistently replicated elsewhere<sup><xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref></sup>. Whole-exome sequencing (WES) is a powerful tool to detect genes causative of not only single-gene disorders, but also multifactorial ones, including autism spectrum disorder<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Regarding PD, to the best of our knowledge, only a few studies have explored genes causative of this condition using next-generation sequencing (NGS)<sup><xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR10">10</xref></sup>.</p>
<p id="Par3">To identify genes related to PD, we performed WES in a Japanese family including several members with PD and identified variants linked to this disorder in this family. After identifying the genes that were candidates for causing PD in this family, the frequencies of all variants of these genes were compared between larger groups of PD cases and controls not related to this family. Here, we describe the results of NGS and the assessment of rare protein-altering variants of potential candidate genes in patients with PD and ethnically matched controls.</p>
</sec>
<sec id="Sec2">
<title>Subjects and methods</title>
<sec id="Sec3">
<title>Clinical presentation of a Japanese family including multiple PD patients</title>
<p id="Par4">The proband (II-12) was a 40-year-old woman (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). She had consulted a psychiatric clinic because of panic attacks and anticipatory anxiety. Her mother and elder sister (I-12 and II-1, respectively) had also consulted a psychiatric clinic because of symptoms similar to those in the proband. All of these three (I-12, II-1, and II-12) had been diagnosed with panic disorder by their attending psychiatrists. Among all affected individuals, three out of six (II-6, III-3, and III-4) had also consulted at a psychiatric hospital because of panic attacks and anticipatory anxiety and been diagnosed with panic disorder, as well as having incongruity of emotional responses, social withdrawal, and lethargy-like negative symptoms of schizophrenia. However, they did not fulfill the criteria for schizophrenia. All affected members in this family have similar panic symptoms in common, including panic attacks and anticipatory anxiety. We considered all of them as being “affected” and estimated that they have a shared disease-causing variant, and thus subjected them to further genetic analysis. Sertraline was effective for the treatment of their panic symptoms in many of the affected individuals. All subjects in this family were evaluated by multiple psychiatrists using the MINI International Neuropsychiatric Interview. All diagnoses of psychiatric diseases were made in accordance with the International Classification of Diseases, revision 10 (ICD-10), and the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). The father of the proband was the second eldest of ten siblings, who had not been suffering from any psychiatric diseases. The eldest sister and brother of the proband (II-1 and II-2, respectively) had never married and had no children. The second eldest sister and brother (II-4 and II-7) and their children (III-1, III-5, and III-6) had also not been suffering from any psychiatric diseases. Detailed information about them is summarized in Fig. <xref ref-type="fig" rid="Fig1">1</xref> and Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>A Japanese family including multiple patients with panic disorder. The arrow indicates the proband. Black circles represent individuals (I-12, II-1, II-6, II-12, III-3, and III-4) diagnosed with panic disorder. Gray circles represent individuals (II-6, III-3, and III-4) diagnosed with panic disorder, who also showed schizophrenia-like symptoms, such as incongruity of emotional responses, social withdrawal, and lethargy. We performed whole-exome sequencing of four family members (I-2, I-12, II-10, and II-12) and direct sequencing of variants in nine family members (I-2, I-11, I-12, I-13, II-1, II-6, II-10, II-12, and III-4)</p></caption><graphic id="d29e554" xlink:href="41398_2017_88_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec4">
<title>Analysis of the mode of inheritance in this family using the SAGE program</title>
<p id="Par5">To explore the mode of inheritance in this family, we performed complex segregation analysis using Statistical Analysis for Genetic Epidemiology, Release 6.4 (SAGE) (<ext-link ext-link-type="uri" xlink:href="http://darwin.cwru.edu/sage/">http://darwin.cwru.edu/sage/</ext-link>). Four of the family members (III-7, III-8, III-9, and III-10) were excluded from this analysis since they had not reached the mean age of the onset of PD (24 years old). We considered four different inheritance models: (a) sporadic model without familial residual association; (b) sporadic model with familial residual association; (c) Mendelian major gene models with autosomal-dominant inheritance; and (d) Mendelian major gene models with autosomal recessive inheritance. Akaike’s Information Criterion (AIC) was used to estimate the best fitting model among these four alternatives.</p>
</sec>
<sec id="Sec5">
<title>Japanese and German PD case–control groups</title>
<p id="Par6">A total of 669 sporadic PD cases and 859 control samples were collected from two countries, Japan and Germany (952 Japanese and 576 German). All of these patients with PD had been diagnosed by psychiatrists in accordance with ICD-10, DSM-III, or DSM-IV. Their details are summarized in Supplementary Table <xref ref-type="media" rid="MOESM2">2</xref>. All participants provided informed consent to undergo genetic research, which was approved by the ethics committees.</p>
</sec>
<sec id="Sec6">
<title>DNA extraction</title>
<p id="Par7">We recruited nine members of this family for this study, namely, five affected and four unaffected individuals (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Genomic DNA was extracted from peripheral blood leukocytes using a QIAamp DNA Midi kit (QIAGEN, Hilden, Germany).</p>
</sec>
<sec id="Sec7">
<title>Whole-exome sequencing</title>
<p id="Par8">We assessed DNA quality using NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA, USA) and Qbit Fluorometer Nucleic Acid Quantification (QIAGEN, Hilden, Germany) and selected four high-quality DNA samples (I-2, I-12, II-10, and II-12) for WES. We performed WES on two affected individuals with PD and two unaffected individuals in this family (Fig. <xref ref-type="fig" rid="Fig1">1</xref>), using Agilent SureSelect Exome Target Enrichment System v5 (Agilent Technologies, Santa Clara, CA, USA), followed by paired-end sequencing on SOLiD 5500xl sequencers (Life Technologies, Carlsbad, CA, USA). Mean depth and coverage rate of all samples are summarized in Supplementary Table <xref ref-type="media" rid="MOESM3">3</xref>.</p>
</sec>
<sec id="Sec8">
<title>Sequencing data analysis</title>
<p id="Par9">Fastq format files were generated by bcl2fastq software. Novoalign software (Novocraft Technologies, Kuala Lumpur, Malaysia) was used to align reads on the hg19/GRCh37 human reference genome sequence. Aligned reads were sorted by Novosort software (Novocraft) and subjected to the marking of PCR and optical duplication by MarkDuplicates in the Picard tools package (<ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link>). The Genome Analysis Toolkit (GATK)<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> was used to perform local realignment (GATK IndelRealigner) and variant call (GATK HaplotypeCaller) was implemented in an in-house workflow management tool<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Single nucleotide variations (SNVs) and insertions/deletions (indels) were annotated using ANNOVAR software<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Substitutions that met the following criteria were selected as “deleterious”: (1) mutations: lead stop gain, stop loss, nonsynonymous, or splice site mutations according to GENCODE basic version 19 downloaded from the UCSC genome browser; (2) alternative allele frequencies at mutation loci ≤0.5% in the following databases: 1000 Genomes Project data on all populations released in October 2014<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>; NIH NHLBI 6515 exome data (<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>); Exome Aggregation Consortium (ExAC) 65000 exome data<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>; Human Genomic Variation Database (HGVD) exome data of 1208 individuals collected in Japan<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>; SNV allele frequency collected from whole-genome sequencing data of 2049 healthy Japanese individuals (2KJPN) (<ext-link ext-link-type="uri" xlink:href="https://ijgvd.megabank.tohoku.ac.jp">https://ijgvd.megabank.tohoku.ac.jp</ext-link>); and (3) mutations not included in the UCSC segmental duplication region.</p>
</sec>
<sec id="Sec9">
<title>Sanger sequencing</title>
<p id="Par10">We performed Sanger sequencing to confirm 127 variants shared among two affected individuals (II-1 and II-12) but absent from an unaffected one (I-2), which emerged from the WES. All primers were designed using Primer3<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Genomic DNA (5 ng) was amplified using KOD FX Neo polymerase (Toyobo, Osaka, Japan) by PCR in 20-μl reactions. PCR mixtures were subjected to the following thermal cycling conditions: initial denaturation at 94 °C for 2 min; 32 cycles of denaturation at 98 °C for 10 s, annealing at 60 °C for 15 s, and extension at 68 °C for 30 s; and then final extension at 68 °C for 5 min. The PCR products were purified with AMPureXP<sup>®</sup> (Agencourt, Beverly, MA, USA) and sequencing reactions were performed using the BigDye Terminator Cycle Sequencing Kit v3.1 (Applied Biosystems, Foster City, CA, USA), in accordance with the manufacturer’s instructions. After purification using CleanSEQ (Agencourt), the PCR products were separated and run on an ABI Genetic Analyzer 3130 (Applied Biosystems) and the electropherograms were evaluated using 4Peaks software (<ext-link ext-link-type="uri" xlink:href="http://nucleobytes.com/4peaks/">http://nucleobytes.com/4peaks/</ext-link>). Ten SNVs/indels were detected in all five affected family members. The original ten variants are summarized in Table <xref ref-type="table" rid="Tab1">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Nine SNVs and one deletion were found in all affected members</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th></th><th></th><th></th><th></th><th colspan="9">Genotypes</th><th>Penetrance</th><th>LOD score</th></tr><tr><th>Gene</th><th>Variants</th><th>Protein change</th><th>dbSNP</th><th>HGVD</th><th>I-12</th><th>II-1</th><th>II-6</th><th>II-12</th><th>III-4</th><th>I-2</th><th>I-11</th><th>I-13</th><th>II-10</th><th></th><th></th></tr></thead><tbody><tr><td>
<italic>ADRA1D</italic>
</td><td>chr20: 4202670; G&gt;A</td><td>p.Arg407Cys</td><td>None</td><td>0.0019</td><td>G/A</td><td>G/A</td><td>G/A</td><td>G/A</td><td>G/A</td><td>G/G</td><td>G/G</td><td>G/G</td><td>G/A</td><td>0.83</td><td>0.827847</td></tr><tr><td>
<italic>ATP8B4</italic>
</td><td>chr15: 50271864; C&gt;T</td><td>p.Trp328X</td><td>rs142863209</td><td>0.0032</td><td>C/T</td><td>C/T</td><td>C/T</td><td>C/T</td><td>C/T</td><td>C/C</td><td>C/T</td><td>C/T</td><td>C/C</td><td>0.71</td><td>0.417835</td></tr><tr><td>
<italic>C10orf120</italic>
</td><td>chr10: 124459278; T&gt;C</td><td>p.Gln10Arg</td><td>None</td><td>0.0014</td><td>T/C</td><td>T/C</td><td>T/C</td><td>T/C</td><td>T/C</td><td>T/T</td><td>T/C</td><td>T/T</td><td>T/T</td><td>0.83</td><td>0.828729</td></tr><tr><td>
<italic>FAM82A2</italic>
</td><td>chr15: 41044217; C&gt;T</td><td>p.Arg116Gln</td><td>rs200285306</td><td>0.0074</td><td>C/T</td><td>C/T</td><td>C/T</td><td>C/T</td><td>C/T</td><td>C/C</td><td>C/T</td><td>C/T</td><td>C/C</td><td>0.71</td><td>0.445693</td></tr><tr><td>
<italic>GALNTL5</italic>
</td><td>chr7: 151711868; A&gt;T</td><td>p.Asp389Val</td><td>rs199860896</td><td>0.0009</td><td>A/T</td><td>A/T</td><td>A/T</td><td>A/T</td><td>A/T</td><td>A/A</td><td>A/T</td><td>A/T</td><td>A/A</td><td>0.71</td><td>0.401112</td></tr><tr><td>
<italic>GANC</italic>
</td><td>chr15: 42631993; T&gt;C</td><td>p.Leu657Pro</td><td>None</td><td>None</td><td>T/C</td><td>T/C</td><td>T/C</td><td>T/C</td><td>T/C</td><td>T/T</td><td>T/C</td><td>T/C</td><td>T/T</td><td>0.71</td><td>0.395025</td></tr><tr><td>
<italic>GFRA4</italic>
</td><td>chr20: 3641457; G&gt;C</td><td>p.Arg176Gly</td><td>None</td><td>None</td><td>G/C</td><td>G/C</td><td>G/C</td><td>G/C</td><td>G/C</td><td>G/G</td><td>G/G</td><td>G/G</td><td>G/C</td><td>0.83</td><td>0.829517</td></tr><tr><td>
<italic>HDHD3</italic>
</td><td>chr9: 116136256; G&gt;-</td><td>p.Arg127fs</td><td>None</td><td>0.0058</td><td>G/-</td><td>G/-</td><td>G/-</td><td>G/-</td><td>G/-</td><td>G/G</td><td>G/-</td><td>G/-</td><td>G/-</td><td>0.63</td><td>0.114774</td></tr><tr><td>
<italic>KIAA0319</italic>
</td><td>chr6: 24582481; G&gt;C</td><td>p.Ser351Cys</td><td>None</td><td>0.0036</td><td>G/C</td><td>G/C</td><td>G/C</td><td>G/C</td><td>G/C</td><td>G/G</td><td>G/C</td><td>G/C</td><td>G/C</td><td>0.63</td><td>0.106594</td></tr><tr><td>
<italic>PLA2G4E</italic>
</td><td>chr15: 42342861; G&gt;T</td><td>p.Thr14Asn</td><td>None</td><td>None</td><td>G/T</td><td>G/T</td><td>G/T</td><td>G/T</td><td>G/T</td><td>G/G</td><td>G/T</td><td>G/T</td><td>G/G</td><td>0.71</td><td>0.395025</td></tr></tbody></table><table-wrap-foot><p>The parameter of the penetrance ratio was varied depending on each phenotype/genotype rate in this family. The The LOD score of two-point linkage analysis were calculated using FASTLINK program.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec10">
<title>Linkage and haplotype analysis of candidate variants</title>
<p id="Par11">We performed linkage analysis of ten potential candidate variants using the MLINK program of the LINKAGE/FASTLINK software package (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/CBBresearch/Schaffer/fastlink.html">https://www.ncbi.nlm.nih.gov/CBBresearch/Schaffer/fastlink.html</ext-link>) assuming a dominant model. The parameter of the penetrance ratio was varied depending on each phenotype/genotype rate in this family (Table <xref ref-type="table" rid="Tab1">1</xref>).</p>
</sec>
<sec id="Sec11">
<title>Mutational analysis of all exons among seven genes</title>
<p id="Par12">We sequenced all exons of the seven genes (<italic>ADRA1D</italic>, <italic>ATP8B4</italic>, <italic>C10orf120</italic>, <italic>GANC</italic>, <italic>GFRA4</italic>, <italic>HDHD3</italic>, and <italic>PLA2G4E</italic>) identified by the above procedure in 573 samples (381 Japanese patients with PD; 96 German patients with PD; 96 German controls) by amplicon sequencing. WES in-house data on 571 Japanese individuals from another project were also used. Primers were designed using Ion Ampliseq Designer (<ext-link ext-link-type="uri" xlink:href="https://www.ampliseq.com/browse.action">https://www.ampliseq.com/browse.action</ext-link>) (Supplementary Table <xref ref-type="media" rid="MOESM4">4</xref>). In amplicon sequencing, all exons within these seven genes were amplified using KAPA2G Multiplex PCR Kit (KAPA Biosystems, Woburn, MA, USA) or KOD Extreme HotStart Polymerase (Toyobo, Osaka, Japan) by PCR. The samples were subjected to the following thermal conditions: initial denaturation at 95 °C for 2 min; and then 25 cycles of denaturation at 95 °C for 30 s, annealing at 60 °C for 120 s, and extension at 72 °C for 120 s. PCR amplicons were sonicated to a size of 180 bp using Covaris E220 (Covaris, Woburn, MA, USA). End-repair, A-tailing, and adapter ligation were performed in accordance with the manufacturer’s protocol for KAPA HTP Library Preparation Kits for Illumina Platforms. After adapter ligation, the samples were amplified using KAPA HiFi HotStart Ready Mix (KAPA Biosystems, Wilmington, MA, USA) by PCR with indexed primers. Samples were subjected to the following thermal cycling conditions: initial denaturation at 98 °C for 45 s; seven cycles of denaturation at 98 °C for 15 s, annealing at 60 °C for 30 s, and extension at 72 °C for 30 s; and final extension at 72 °C for 1 min. Prepared amplicon libraries were sequenced using HiSeq 2500 (Illumina). The mean depth of all samples is summarized in Supplementary Table <xref ref-type="media" rid="MOESM5">5</xref>.</p>
</sec>
<sec id="Sec12">
<title>Single-variant association test</title>
<p id="Par13">To detect the single variants associated with PD, we used PLINK<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> to estimate <italic>p</italic> value and odds ratios. In this study, we filtered out the variants using the following criteria: alternative allele frequencies of less than 0.005 in the samples in this study, exact test of Hardy–Weinberg equilibrium: <italic>p</italic> &lt; 1 × 10<sup>−6</sup>, and call rates of less than 90%. In total, 16 and 19 variants were found in the Japanese and Germans, respectively, so the significant thresholds of <italic>p</italic> values were set to 0.0031 in the Japanese and 0.0026 in the Germans, in accordance with Bonferroni correction.</p>
</sec>
<sec id="Sec13">
<title>Gene-based rare variant association tests</title>
<p id="Par14">To test differences in the mutational burden of the candidate genes, we used Efficient and Parallelizable Association Container Toolbox (EPACTS). In the EPACTS algorithms, we used three different analyses (CMC<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, Madsen–Browning<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, and SKAT-O<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>). We removed common variants using the following criteria: alternative allele frequency of more than 0.005 in any public database (ExAC, ESP6500, 1000 Genomes, HGVD, and ToMMo 2KJPN) or more than 0.005 in control samples in this study; call rate of less than 90% in the study samples; and genotyping quality score of less than 99. In German samples, <italic>GFRA4</italic> was removed from the analysis because of the lack of a variant allele. The significance threshold here was set to 0.0167, in accordance with Bonferroni correction.</p>
</sec>
</sec>
<sec id="Sec14" sec-type="results">
<title>Results</title>
<sec id="Sec15">
<title>Segregation analysis</title>
<p id="Par15">The segregation analysis using SAGE algorithms showed that the “Mendelian major gene models with autosomal-dominant inheritance,” which was the plausible mode of inheritance in this family. This result indicated that this family carries a single locus with a strong impact on PD. The AIC scores are summarized in Supplementary Table <xref ref-type="media" rid="MOESM6">6</xref>.</p>
</sec>
<sec id="Sec16">
<title>Linkage analysis</title>
<p id="Par16">Two-point logarithm of the odd (LOD) scores were calculated by FASTLINK software. The LOD scores of ten variants are summarized in Table <xref ref-type="table" rid="Tab1">1</xref>.</p>
</sec>
<sec id="Sec17">
<title>Whole-exome sequencing and Sanger sequencing</title>
<p id="Par17">We identified 127 functionally significant variants shared by the two affected individuals subjected to WES. To identify compelling candidates, we searched variants shared among all affected members by Sanger sequencing of these 127 variants (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). As a result, nine SNVs and one deletion were found in all affected members (Table <xref ref-type="table" rid="Tab1">1</xref>).</p>
</sec>
<sec id="Sec18">
<title>Mutational screening of seven familial substitutions in Japanese and German PD case–control groups</title>
<p id="Par18">To examine the allele frequencies of these candidate alterations, we screened these substitutions in Japanese and Germans with or without PD (Supplementary Table <xref ref-type="media" rid="MOESM2">2</xref>). In the Japanese (384 patients with PD and 571 matched controls), we found some SNVs that had been identified in the WES (chr20: 4202670, G&gt;A in <italic>ADRA1D</italic>; chr15: 50271864, C&gt;T in <italic>ATP8B4</italic>; chr10: 124459278, T&gt;C in <italic>C10orf12</italic>0; chr9: 116136256, G&gt;- in <italic>HDHD3</italic>). These four variants were also observed in controls. Furthermore, none of these variants showed a significant preponderance in PD cases relative to the level in controls, so they were considered to be polymorphisms that did not have a major role in the development of PD. However, three SNVs (chr15: 42631993, T&gt;C in <italic>GANC</italic>; chr15: 42342861, G&gt;T in <italic>PLA2G4E</italic>; chr20: 3641457, G&gt;C in <italic>GFRA4</italic>) were “novel variants,” since they were not observed in controls or in any databases and their allele frequencies and estimated pathogenic impact could not be evaluated (Table <xref ref-type="table" rid="Tab2">2</xref>). Taking these findings together, we considered these three SNVs to be potential pathogenic variants in this family (Table <xref ref-type="table" rid="Tab2">2</xref>). In contrast, in the Germans (288 patients and 288 controls), none of these seven variants was found in either patients or controls.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Allele counts of familial SNVs/Indels in Japanese PD case–control cohorts</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Variants</th><th colspan="2">Mutation allele counts</th><th colspan="3">Allele frequency</th><th><italic>P</italic> value</th><th>OR</th></tr><tr><th></th><th></th><th>PD (<italic>N</italic> = 957)</th><th>Control (<italic>N</italic> = 1718)</th><th>HGVD</th><th>ExAC03</th><th>ESP6500</th><th></th><th></th></tr></thead><tbody><tr><td>
<italic>ADRA1D</italic>
</td><td>chr20: 4202670; G&gt;A</td><td>0</td><td>1</td><td>0.0019</td><td>0.0002</td><td>0.00313</td><td>1</td><td>0.5</td></tr><tr><td>
<italic>ATP8B4</italic>
</td><td>chr15: 50271864; C&gt;T</td><td>2</td><td>3</td><td>0.0032</td><td>0.0002</td><td>0.003173</td><td>1</td><td>1</td></tr><tr><td>
<italic>C10orf120</italic>
</td><td>chr10: 124459278; T&gt;C</td><td>2</td><td>2</td><td>0.0014</td><td>1.68E−05</td><td>0.00187</td><td>1</td><td>1.5</td></tr><tr><td>
<italic>GANC</italic>
</td><td>chr15: 42631993; T&gt;C</td><td>0</td><td>0</td><td>None</td><td>None</td><td>None</td><td>NA</td><td>NA</td></tr><tr><td>
<italic>GFRA4</italic>
</td><td>chr20: 3641457; G&gt;C</td><td>0</td><td>0</td><td>None</td><td>None</td><td>None</td><td>NA</td><td>NA</td></tr><tr><td>
<italic>HDHD3</italic>
</td><td>chr9: 116136256; G&gt;-</td><td>1</td><td>3</td><td>0.0005</td><td>8.25E−06</td><td>0.001166</td><td>0.6539</td><td>0.5</td></tr><tr><td>
<italic>PLA2G4E</italic>
</td><td>chr15: 42342861; G&gt;T</td><td>0</td><td>0</td><td>None</td><td>None</td><td>None</td><td>NA</td><td>NA</td></tr></tbody></table><table-wrap-foot><p><italic>P</italic> values and odds ratio were estimated by Fisher’s exact test</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec19">
<title>Single-variant association test</title>
<p id="Par19">To identify unique loci associated with PD in the three candidate genes containing the SNVs mentioned above (<italic>GANC</italic>, <italic>GFRA4</italic>, and <italic>PLA2G4E</italic>), we tested 27 SNVs identified by amplicon sequencing using PLINK. The results showed that no single loci were significantly associated with PD in both Japanese and Germans (Table <xref ref-type="table" rid="Tab3">3</xref> and Supplementary Tables <xref ref-type="media" rid="MOESM7">7</xref> and <xref ref-type="media" rid="MOESM8">8</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Results of single-variant association tests</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Variants</th><th colspan="2">Mutation allele counts</th><th><italic>P</italic> value</th><th>OR</th></tr></thead><tbody><tr><td>Japan gene</td><td></td><td>PD (<italic>N</italic> = 762)</td><td>Control (<italic>N</italic> = 1142)</td><td></td><td></td></tr><tr><td>
<italic> PLA2G4E</italic>
</td><td>chr15: 42298189; C&gt;T</td><td>12</td><td>7</td><td>0.06299</td><td>2.434</td></tr><tr><td>
<italic> GFRA4</italic>
</td><td>chr20: 3640641; A&gt;G</td><td>12</td><td>8</td><td>0.069</td><td>2.3</td></tr><tr><td>
<italic> GANC</italic>
</td><td>chr15: 42643538; G&gt;A</td><td>53</td><td>60</td><td>0.1659</td><td>1.329</td></tr><tr><td>
<italic> GANC</italic>
</td><td>chr15: 42579984; A&gt;G</td><td>52</td><td>60</td><td>0.197</td><td>1.299</td></tr><tr><td>
<italic> PLA2G4E</italic>
</td><td>chr15: 42292389; A&gt;G</td><td>2</td><td>8</td><td>0.2098</td><td>0.3507</td></tr><tr><td>Germany gene</td><td></td><td>PD (<italic>N</italic> = 192)</td><td>Control (<italic>N</italic> = 192)</td><td></td><td></td></tr><tr><td>
<italic> GANC</italic>
</td><td>chr15: 42619508; C&gt;T</td><td>15</td><td>25</td><td>0.09344</td><td>0.539</td></tr><tr><td>
<italic> GFRA4</italic>
</td><td>chr20: 3640823; C&gt;T</td><td>96</td><td>75</td><td>0.0971</td><td>1.427</td></tr><tr><td>
<italic> GFRA4</italic>
</td><td>chr20: 3644082; T&gt;C</td><td>1</td><td>5</td><td>0.1168</td><td>0.1895</td></tr><tr><td>
<italic> GANC</italic>
</td><td>chr15: 42579984; A&gt;G</td><td>17</td><td>9</td><td>0.1543</td><td>1.933</td></tr><tr><td>
<italic> GANC</italic>
</td><td>chr15: 42631928; C&gt;T</td><td>17</td><td>24</td><td>0.1892</td><td>0.6387</td></tr></tbody></table><table-wrap-foot><p>Top five loci are displayed with the lowest <italic>p</italic> value first. The significance thresholds were as follows: Japan, 0.0031; and Germany, 0.0026</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec20">
<title>Gene-based rare variant association tests</title>
<p id="Par20">To examine whether there was an excess of rare mutations resulting in protein alterations of three genes (<italic>GANC</italic>, <italic>GFRA4</italic>, and <italic>PLA2G4E</italic>) in patients with PD compared with their levels in controls, we performed gene-based rare variant association tests using EPACTS algorithms. In the Japanese group (384 patients and 571 controls), <italic>PLA2G4E</italic> showed the lowest <italic>p</italic> values (<italic>p</italic> = 0.0715 in CMC, <italic>p</italic> = 0.0658 in Madsen–Browning, <italic>p</italic> = 0.1624 in SKAT-O), but did not reach the significance threshold. <italic>PLA2G4E</italic> also showed the lowest <italic>p</italic> values (<italic>p</italic> = 0.0652 in CMC, <italic>p</italic> = 0.0347 in Madsen–Browning, <italic>p</italic> = 0.0646 in SKAT-O) in the German population (Table <xref ref-type="table" rid="Tab4">4</xref> and Supplementary Tables <xref ref-type="media" rid="MOESM9">9</xref> and <xref ref-type="media" rid="MOESM10">10</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Results of gene-based rare variant association tests</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Number of markers</th><th><italic>P</italic> value CMC</th><th>Madsen–Browing</th><th>SKAT-O</th></tr></thead><tbody><tr><td colspan="5">Japanese gene</td></tr><tr><td>
<italic> GANC</italic>
</td><td>6</td><td>0.9977</td><td>0.9939</td><td>0.5172</td></tr><tr><td>
<italic> GFRA4</italic>
</td><td>3</td><td>0.9744</td><td>0.1026</td><td>0.1699</td></tr><tr><td>
<italic> PLA2G4E</italic>
</td><td>12</td><td>0.0715</td><td>0.0658</td><td>0.1624</td></tr><tr><td colspan="5">Germany gene</td></tr><tr><td>
<italic> GANC</italic>
</td><td>5</td><td>0.2751</td><td>0.2645</td><td>0.415</td></tr><tr><td>
<italic> PLA2G4E</italic>
</td><td>6</td><td>0.0652</td><td>0.0347</td><td>0.0646</td></tr></tbody></table><table-wrap-foot><p>The significance threshold was set to 0.0167</p></table-wrap-foot></table-wrap></p>
</sec>
</sec>
<sec id="Sec21" sec-type="discussion">
<title>Discussion</title>
<p id="Par21">In this study, we focused on rare protein-altering variants in a Japanese family, including multiple patients, with PD to identify genetic variants contributing to the risk of this disorder. Recent studies have indicated that the genetic risk of psychiatric disorders involves the combined effects of many common variants of small effect, as well as rare variants of large effect including gene-disrupting mutations that might have a strong impact on the development of diseases<sup><xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR24">24</xref></sup>. They have also suggested the possibility that an extremely large effect of even just a single variant could cause diseases. In the present study, we hypothesized that there may be rare highly penetrant mutations with a very large effect in this family; this was supported by the findings of affected individuals through three generations and the autosomal-dominant inheritance mode identified from the segregation analysis. Assuming that the penetrance of the rare mutation was going to be high with incomplete penetrance, there is a possibility that the siblings of the proband were inherited the rare mutation with a large effect. First, for primary candidates, we selected variants that all affected individuals carried but that the father of the proband did not carry from the results of both WES and Sanger sequencing, resulting in ten variants remaining. The LOD score of these ten candidates was in the range of 0.11–0.83. Given the small family size here, it is unlikely that a LOD score of 3 would be achieved<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The LOD score &gt;0 obtained here should not be overlooked in this particular case of a single small family. Next, we filtered out three of these ten variants since three SNVs that had already been registered in the dbSNP database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/SNP/">https://www.ncbi.nlm.nih.gov/SNP/</ext-link>) or showed a high allele frequency (&gt;0.003) in the HGVD database; however, we included a nonsense mutation in <italic>ATP8B</italic> and a one-base deletion in <italic>HDHD3</italic> are included due to them having a high probability of being deleterious mutations (Table <xref ref-type="table" rid="Tab1">1</xref>). Thus, we selected seven variants as being potentially pathogenic in this family. Subsequently, we eliminated four of these seven candidate variants since none of them showed significant accumulations in PD from the results of sequencing of our case–control group, despite each allele frequency being less than 0.003 in a public database. Seven variants were thus eliminated from the primary ten candidates because they were assumed to have very low penetrance. Recent studies have also suggested that minor allele frequencies have a strong association with their odds ratios<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>, which supported our filtering strategy. As a result of this filtering, we identified three rare protein-altering variants as potential disease-causing candidates after resequencing and filtering. We then performed mutational burden analyses of these three potential candidate genes. A single-variant association test of these three potential candidates did not show any association with PD. Because association testing using common single variants is effective for detecting loci with small phenotypic effects<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>; GWAS is a suitable method to detect common loci associated with complex diseases including psychiatric conditions<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>. GWAS focusing on PD has already been reported in the Japanese and German populations, which identified several candidate genes (e.g., <italic>TMEM132D</italic>, <italic>PKP1</italic>, <italic>PLEKHG1</italic>, and <italic>CLU</italic>)<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>, although these do not overlap with the three candidate genes identified in the present study. In gene-based rare variant association tests, <italic>PLA2G4E</italic> showed the lowest <italic>p</italic> value among the three candidates in this study, but did not reach the significance threshold in either the Japanese or the German group. There are several possible explanations for this. First, the significance threshold after Bonferroni correction might be too stringent to achieve the precise detection of meaningful variants in gene-based rare variant methods. Recent studies have indicated that existing gene-based rare variant methods might not be able to detect disease-related variants at the exome-wide significance threshold despite the effect size of variants being relatively large<sup><xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR33">33</xref></sup>. They also suggested that the absence of a positive signal in gene-based association studies does not exclude a role of rare variation in diseases. The second possibility is that the effect size of variants is not so large. Moutsianas et al. demonstrated that the power of detection in gene-based association tests is inversely related to the degree of linkage disequilibrium between causal variants at a locus<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. The effect size of three potential candidates might have influenced to our negative results. The last possible explanation is that the sample size was too small. To boost the statistical power of the gene-based rare variant association method, it is usually necessary to increase the sample size<sup><xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref></sup>. A small sample size is thus one of the limitations of our study.</p>
<p id="Par22">To the best of our knowledge, no study has yet reported an association between <italic>PLA2G4E</italic> and PD. <italic>PLA2G4E</italic> is very poorly characterized, although a few studies have revealed its functions. For example, Ohto et al. demonstrated that recombinant PLA2G4E influences phospholipase activity<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, while Ogura et al. showed that it is strongly expressed in the brain, especially in neurons, and regulates bioactive lipids, namely, <italic>N</italic>-acyl phosphatidylethanolamines and <italic>N</italic>-acyl ethanolamines including the endocannabinoid anandamide, by mobilizing intracellular calcium in mammalian cells<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. They also surmised that the PLA2G4E-regulated pathway might provide new therapeutic strategies for neuropsychiatric diseases. Interestingly, in recent years, a number of studies have presented evidence for the involvement of the endocannabinoid system (ECS) in PD<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. The cannabinoid type 1 receptors influence the glutamatergic and GABAergic regulation of anxiety and fear response, which can be recognized as a key regulatory element in the pathogenesis of PD<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. However, functional analyses of variants of <italic>PLA2G4E</italic> have yet to be performed, which are needed to draw definitive conclusions on the causal association between these variants in <italic>PLA2G4E</italic> and ECS/neurotransmitter release.</p>
<p id="Par23">In conclusion, we failed to identify any genes responsible for the development of PD through exome sequencing in a Japanese family featuring multiple patients with PD as well as through a case–control study. <italic>PLA2G4E</italic> showed the lowest <italic>p</italic> value among the three candidates in this study in both of the two different ethnic groups; however, none of the genes or variants reached the threshold for statistical significance. Nonetheless, considering both our genetic findings and protein functions, the possibility remains that <italic>PLA2G4E</italic> could be involved in the pathogenesis of PD and become a new therapeutic target for this disorder.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec22">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41398_2017_88_MOESM1_ESM.xlsx"><caption><p>Supplementary Table 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41398_2017_88_MOESM2_ESM.xlsx"><caption><p>Supplementary Table 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41398_2017_88_MOESM3_ESM.xlsx"><caption><p>Supplementary Table 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41398_2017_88_MOESM4_ESM.xlsx"><caption><p>Supplementary Table 4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41398_2017_88_MOESM5_ESM.xlsx"><caption><p>Supplementary Table 5</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41398_2017_88_MOESM6_ESM.xlsx"><caption><p>Supplementary Table 6</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41398_2017_88_MOESM7_ESM.xlsx"><caption><p>Supplementary Table 7</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41398_2017_88_MOESM8_ESM.xlsx"><caption><p>Supplementary Table 8</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="41398_2017_88_MOESM9_ESM.xlsx"><caption><p>Supplementary Table 9</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="41398_2017_88_MOESM10_ESM.xlsx"><caption><p>Supplementary Table 10</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p><bold>Supplementary Information</bold> accompanies this paper at 10.1038/s41398-017-0088-0.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We thank the members of the family for participating in this study. We also thank Chisa Hayashida for technical support with the NGS. This work was supported in part by a grant from Senshin Medical Research Foundation (S.O.); the Initiative on Rare Undiagnosed Diseases in Pediatrics (IRUD-P) project (K.Y.), and the Practical Research Project for Rare/Intractable Diseases from the Agency for Medical Research and Development; Grants-in-Aid for Scientific Research (B) (K.Y.) and (C) (A.K. and S.O.) from the Japan Society for the Promotion of Science; and Takeda Scientific Foundation (K.Y.). We also thank Edanz Group (<ext-link ext-link-type="uri" xlink:href="http://www.edanzediting.com/ac">www.edanzediting.com/ac</ext-link>) for editing a draft of this manuscript.</p>
</ack>
<notes notes-type="author-contribution">
<title>Author contributions</title>
<p>Conception and design of the study: S.O. and K.-i.Y. Analysis and interpretation of data: Y.M., M.S.-S., T.O., S.Y., A.K., H.M., N.Y., T.M., A.I., H.O., N.K., C.Z., K.D., J.D., T.U., M.T., H.K., Y.O., K.T., T.S., S.O., and K.-i.Y. Manuscript preparation: Y.M. and S.O. Final approval of the article: K.-i.Y.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Conflict of interest</title>
<p id="Par24">The authors declare that they have no conflict of interest.</p>
</sec>
<sec id="FPar2">
<title>Ethics regarding human subjects</title>
<p id="Par25">Experimental procedures were approved by the Committee for the Ethical Issues on Human Genome and Gene Analysis at Nagasaki University. The methods were carried out in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kessler</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lifetime panic-depression comorbidity in the National Comorbidity Survey</article-title>
<source/>Arch. Gen. Psychiatry
          <year>1998</year>
<volume>55</volume>
<fpage>801</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.55.9.801</pub-id>
<pub-id pub-id-type="pmid">9736006</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldstein</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Wickramaratne</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Horwath</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Familial aggregation and phenomenology of ‘early’-onset (at or before age 20 years) panic disorder</article-title>
<source/>Arch. Gen. Psychiatry
          <year>1997</year>
<volume>54</volume>
<fpage>271</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.1997.01830150097014</pub-id>
<pub-id pub-id-type="pmid">9075468</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hettema</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kendler</surname>
<given-names>KS</given-names>
</name>
</person-group>
<article-title>A review and meta-analysis of the genetic epidemiology of anxiety disorders</article-title>
<source/>Am. J. Psychiatry
          <year>2001</year>
<volume>158</volume>
<fpage>1568</fpage>
<lpage>1578</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.158.10.1568</pub-id>
<pub-id pub-id-type="pmid">11578982</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gelernter</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linkage genome scan for loci predisposing to panic disorder or agoraphobia</article-title>
<source/>Am. J. Med. Genet.
          <year>2001</year>
<volume>105</volume>
<fpage>548</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1496</pub-id>
<pub-id pub-id-type="pmid">11496373</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fyer</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci</article-title>
<source/>Biol. Psychiatry
          <year>2006</year>
<volume>60</volume>
<fpage>388</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.04.018</pub-id>
<pub-id pub-id-type="pmid">16919526</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otowa</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Replication of a genome-wide association study of panic disorder in a Japanese population</article-title>
<source/>J. Hum. Genet.
          <year>2010</year>
<volume>55</volume>
<fpage>91</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2009.127</pub-id>
<pub-id pub-id-type="pmid">19960027</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helsmoortel</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP</article-title>
<source/>Nat. Genet.
          <year>2014</year>
<volume>46</volume>
<fpage>380</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2899</pub-id>
<pub-id pub-id-type="pmid">24531329</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregersen</surname>
<given-names>NO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole-exome sequencing implicates DGKH as a risk gene for panic disorder in the Faroese population</article-title>
<source/>Am. J. Med. Genet. B
          <year>2016</year>
<volume>171</volume>
<fpage>1013</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32464</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faqeih</surname>
<given-names>EA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel homozygous DEAF1 variant suspected in causing white matter disease, intellectual disability, and microcephaly</article-title>
<source/>Am. J. Med. Genet. A
          <year>2014</year>
<volume>164</volume>
<fpage>1565</fpage>
<lpage>1570</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36482</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>BZ</given-names>
</name>
<name>
<surname>Gelernter</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The role and challenges of exome sequencing in studies of human diseases</article-title>
<source/>Front. Genet.
          <year>2013</year>
<volume>26</volume>
<fpage>160</fpage>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
<source/>Genome Res.
          <year>2010</year>
<volume>20</volume>
<fpage>1297</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
<pub-id pub-id-type="pmid">20644199</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tatebe</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Yoshiura</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Agile parallel bioinformatics workflow management using Pwrake</article-title>
<source/>BMC Res. Notes
          <year>2011</year>
<volume>4</volume>
<fpage>331</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1186/1756-0500-4-331</pub-id>
<pub-id pub-id-type="pmid">21899774</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>ANNOVAR: functional annotation of genetic variants from next-generation sequencing data</article-title>
<source/>Nucleic Acids Res.
          <year>2010</year>
<volume>38</volume>
<fpage>e164</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
<pub-id pub-id-type="pmid">20601685</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>1000 Genomes Projects Consortium</collab>
<name>
<surname>Auton</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A global reference for human genetic variation</article-title>
<source/>Nature
          <year>2015</year>
<volume>526</volume>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1038/nature15393</pub-id>
<pub-id pub-id-type="pmid">26432245</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of protein-cording genetic variation in 60,706 humans</article-title>
<source/>Nature
          <year>2016</year>
<volume>536</volume>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higasa</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human genetic variation database, a reference database of genetic variations in Japanese population</article-title>
<source/>J. Hum. Genet.
          <year>2016</year>
<volume>61</volume>
<fpage>547</fpage>
<lpage>553</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2016.12</pub-id>
<pub-id pub-id-type="pmid">26911352</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Skaletsky</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Primer3 on the WWW for general users and for biologist programmers</article-title>
<source/>Methods Mol. Biol.
          <year>2000</year>
<volume>132</volume>
<fpage>365</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="pmid">10547847</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PLINK: a tool set for whole-genome assotiation and population-based linkage analyses</article-title>
<source/>Am. J. Hum. Genet.
          <year>2007</year>
<volume>81</volume>
<fpage>559</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="doi">10.1086/519795</pub-id>
<pub-id pub-id-type="pmid">17701901</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Leal</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data</article-title>
<source/>Am. J. Hum. Genet.
          <year>2008</year>
<volume>83</volume>
<fpage>311</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2008.06.024</pub-id>
<pub-id pub-id-type="pmid">18691683</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madsen</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Browing</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>A groupwise association test for rare mutations usinng a weighted sum statistic</article-title>
<source/>PLoS. Genet.
          <year>2009</year>
<volume>5</volume>
<fpage>e1000384</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000384</pub-id>
<pub-id pub-id-type="pmid">19214210</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Optimal unilied approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies</article-title>
<source/>Am. J. Hum. Genet.
          <year>2012</year>
<volume>91</volume>
<fpage>224</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.06.007</pub-id>
<pub-id pub-id-type="pmid">22863193</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gratten</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wray</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Visscher</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>Large-scale genomics unveils the genetic architecture of psychiatric disorders</article-title>
<source/>Nat. Neurosci.
          <year>2014</year>
<volume>17</volume>
<fpage>782</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3708</pub-id>
<pub-id pub-id-type="pmid">24866044</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo gene disruptions in children on the autistic spectrum</article-title>
<source/>Neuron
          <year>2012</year>
<volume>74</volume>
<fpage>285</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.009</pub-id>
<pub-id pub-id-type="pmid">22542183</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations revealed by whole-exome sequencing are strongly associated with autism</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<fpage>237</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1038/nature10945</pub-id>
<pub-id pub-id-type="pmid">22495306</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A clinical and molecular genetic study of a rare dominantly inherited syndrome (MRCS) comprising of microcornea, rod-cone dystrophy, cataract, and posterior staphyloma</article-title>
<source/>Br. J. Ophthalmol.
          <year>2003</year>
<volume>87</volume>
<fpage>197</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.87.2.197</pub-id>
<pub-id pub-id-type="pmid">12543751</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiezun</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exome sequencing and the genetic bases of complex traits</article-title>
<source/>Nat. Genet.
          <year>2012</year>
<volume>44</volume>
<fpage>623</fpage>
<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2303</pub-id>
<pub-id pub-id-type="pmid">22641211</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manolio</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Genome-wide association studies and assessment of risk of disease</article-title>
<source/>N. Engl. J. Med.
          <year>2010</year>
<volume>363</volume>
<fpage>166</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra0905980</pub-id>
<pub-id pub-id-type="pmid">20647212</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gelernter</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Genetics of complex traits in psychiatry</article-title>
<source/>Biol. Psychiatry
          <year>2015</year>
<volume>77</volume>
<fpage>36</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.08.005</pub-id>
<pub-id pub-id-type="pmid">25444161</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erhardt</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TMEM132D, a new candidate for anxiety phenotypes: evidence form human and mouse studies</article-title>
<source/>Mol. Psychiatry
          <year>2011</year>
<volume>16</volume>
<fpage>647</fpage>
<lpage>663</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2010.41</pub-id>
<pub-id pub-id-type="pmid">20368705</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moutsianas</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease</article-title>
<source/>PLoS. Genet.
          <year>2015</year>
<volume>11</volume>
<fpage>e1005165</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005165</pub-id>
<pub-id pub-id-type="pmid">25906071</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Determinants of power in gene-based burden testing for monogenic disorders</article-title>
<source/>Am. J. Hum. Genet.
          <year>2016</year>
<volume>99</volume>
<fpage>527</fpage>
<lpage>539</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.06.031</pub-id>
<pub-id pub-id-type="pmid">27545677</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sham</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Statistical power and significance testing in large-scale genetic studies</article-title>
<source/>Nat. Rev. Genet.
          <year>2014</year>
<volume>15</volume>
<fpage>335</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3706</pub-id>
<pub-id pub-id-type="pmid">24739678</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<mixed-citation publication-type="other">Wang M., Ma W. &amp; Zhou Y. Association detection between ordinal trait and rare variants based on adaptive combination of <italic>P</italic> values. <italic>J. Hum. Genet.</italic>10.1038/s10038-017-0354-2 (2017).</mixed-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uozumi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hirabayashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Identification of novel cytosolic phospholipase A(2)s, murine cPLA(2){delta},{epsilon}, and {zeta}, which form a gene cluster with cPLA(2){beta}</article-title>
<source/>J. Biol. Chem.
          <year>2005</year>
<volume>280</volume>
<fpage>24576</fpage>
<lpage>24583</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M413711200</pub-id>
<pub-id pub-id-type="pmid">15866882</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Kamat</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Cravatt</surname>
<given-names>BF</given-names>
</name>
</person-group>
<article-title>A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines</article-title>
<source/>Nat. Chem. Biol.
          <year>2016</year>
<volume>12</volume>
<fpage>669</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1038/nchembio.2127</pub-id>
<pub-id pub-id-type="pmid">27399000</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batista</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Basto</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Role of endocannabinoid signaling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses</article-title>
<source/>J. Psychopharmacol.
          <year>2015</year>
<volume>29</volume>
<fpage>334</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1177/0269881114566259</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viana</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Hott</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Resstel</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Aguiar</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model pf panic attack in rats</article-title>
<source/>Psychopharmacology
          <year>2015</year>
<volume>232</volume>
<fpage>1545</fpage>
<lpage>1553</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-014-3793-x</pub-id>
<pub-id pub-id-type="pmid">25388290</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruehle</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Remmers</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lutz</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The endocannabinoid system in anxiety, fear memory and habituation</article-title>
<source/>J. Psychopharmacol.
          <year>2012</year>
<volume>26</volume>
<fpage>23</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1177/0269881111408958</pub-id>
<pub-id pub-id-type="pmid">21768162</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>